OR3-002 – Blau Syndrome cohort study: ocular outcome

نویسندگان

  • CD Rose
  • R Cimaz
  • C Thomee
  • R Khubchandani
  • G Espada
  • R Russo
  • M Harjacek
  • B Bader-Meunier
  • P Brissaud
  • N Wulffraat
  • S Vastert
  • R Merino
  • A Naranjo-Hernandez
  • S Oliveira Knupp
  • F Mackenson
  • J Arostegui
  • J Anton Lopez
  • J Fernandez-Martin
  • C Wouters
چکیده

Introduction BS is an autosomal dominant monogenic granulomatous disease due to gain of function mutations at or near the NACHT domain of NOD2. It is characterized by a triad of granulomatous polyarthritis, uveitis and rash. Retrospective work by our group showed a life time risk of ocular involvement of 60% with significant morbidity and poor visual outcome. Prospective studies on natural history of visual outcome are not available. In view of current lack of effective therapies, research on relevant pathways downstream NOD2 is essential and may lead to appropriate targeted drug development.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

OR3-001 – RIP2 kinase is activated in Blau Syndrome and IBD

Introduction Blau Syndrome (Blau) is a granulomatous auto-inflammatory disease caused by mutations in NOD2 that have been proposed to result in phosphorylation of RIP2 kinase and the production of pro-inflammatory cytokines. Such monogenic diseases can bring to light pathways that are also likely to be involved in more genetically complex diseases. For example, increased RIP2 phosphorylation ha...

متن کامل

A Case of Blau Syndrome

We present a case of systemic granulomatous disorder/Blau syndrome. A patient was seen at our clinic with a diagnosis of Juvenile Idiopathic Arthritis (JIA). He was diagnosed with polyarticular JIA when he was two years old, at that time primary manifestations included inflammation of the hand and wrist joints bilaterally, later he developed ocular symptoms, which were attributed to JIA. He had...

متن کامل

A new mutation in blau syndrome: case report

Introduction Blau syndrome is a rare autoinflamattory granulomatous disease and inherited as autosomal dominant.The classical triad of Blau syndrome is granulomatous dermatitis, symmetric arthritis and recurrent uveitis. However, all of these findings may not be together in the patients. In the majority of patients, the disease is characterized by early onset that usually before 3-4 years of ag...

متن کامل

PW03-016 – Blau prospective cohort study: articular outcomes

Introduction Blau syndrome is an autosomal dominant monogenic granulomatous disease associated with gain of function mutations at or near the NACHT domain of NOD2; it is the only form of granulomatous arthritis with a known gene mutation. Although its phenotype has been amply described as a triad of arthritis, uveitis and dermatitis in case series and retrospective cohorts, prospective studies ...

متن کامل

Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.

OBJECTIVES To describe the acute and late ocular manifestations of toxic epidermal necrosis (TEN), Stevens-Johnson syndrome (SJS), and overlap syndrome and to identify predictors for the development of ocular complications. DESIGN Retrospective cohort study. SETTING A single referral unit in a university hospital. PATIENTS The study included 159 patients (mean [SD] age, 49.9 [19.8] years)...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 11  شماره 

صفحات  -

تاریخ انتشار 2013